Nancy Lurker - 14 Jun 2021 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
President & CEO, Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
15 Jun 2021, 17:04:41 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +4,500 +4.1% $0.000000 113,546 14 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Options Exercise $0 -4,500 -100% $0.000000* 0 14 Jun 2021 Common Stock 4,500 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in three annual installments beginning on 14-Jun-2019